The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy

The Ratio of IP10 to IL-8 in Plasma Reflects and Predicts the Response of Patients With Lung Cancer to Anti-PD-1 Immunotherapy Combined With Chemotherapy

Antibodies against checkpoint inhibitors such as anti-programmed cell death protein 1 (PD-1) and its ligand anti-programmed death ligand 1 (PD-L1) have shown clinical efficacy in the treatment of multiple cancers. However, there are only a few studies on biomarkers for these targeted immunotherapies...

Full description

Bibliographic Details
Main Authors: Liangliang Wu, Shengzhi Xie, Lingxiong Wang, Jinfeng Li, Lu Han, Boyu Qin, Guoqing Zhang, Qiyan Wu, Wenjuan Gao, Lijun Zhang, Huafeng Wei, Tianyi Liu, Shunchang Jiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
combination therapy
immunotherapy
cytokines
IP10
IL-8
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.665147/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.665147/full

Similar Items